Publications by authors named "Maria Bassanelli"

Claim this Profile
C
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Veronica Mollica, Francesco Massari, Marco Maruzzo, Davide Bimbatti, Melanie Claps, Maria Bassanelli

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Maria Bassanelli, Melissa Bersanelli

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Francesco Massari, Matteo Santoni, Hideki Takeshita, Yohei Okada, Jose Carlos Tapia, Maria Bassanelli

Cancer Immunol Immunother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Matteo Santoni, Sebastiano Buti, Zin W Myint, Marco Maruzzo, Roberto Iacovelli, Maria Bassanelli

Eur Urol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Yohei Okada, Francesco Massari, Maria Bassanelli

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Maria Bassanelli

Clin Genitourin Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, Zin W Myint, Nicolò Cavasin, Maria Bassanelli

Minerva Urol Nephrol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Maria Bassanelli

Target Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Matteo Santoni, Javier Molina-Cerrillo, Zin W Myint, Francesco Massari, Tomas Buchler, Maria Bassanelli

Target Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study.
Maria Bassanelli, Biagio Ricciuti, Diana Giannarelli, Fabiana Letizia Cecere, Michela Roberto

Tumori· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC.
Maria Bassanelli, Sara Ramella, Massimo Zeuli, Anna Ceribelli

Anticancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Umberto Basso, Giuseppe Procopio, Giuseppe Fornarini, Francesco Massari, Alessandra Bearz, Maria Bassanelli

Oncology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Maria Bassanelli, Marina Borro, Michela Roberto, Diana Giannarelli, Silvana Giacinti

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?
Chiara Pozzessere, Maria Bassanelli, Anna Ceribelli, Sazan Rasul, Shuren Li

Curr Urol Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.
Biagio Ricciuti, Carlo Genova, Maria Bassanelli, Andrea De Giglio, Marta Brambilla

Clin Lung Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.
Biagio Ricciuti, Carlo Genova, Andrea De Giglio, Maria Bassanelli, Maria Giovanna Dal Bello

J Cancer Res Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC.
Silvana Giacinti, Giulia Poti, Michela Roberto, Serena Macrini, Maria Bassanelli

Anticancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC.
Maria Bassanelli, Stefano Sioletic, Maurizio Martini, Silvana Giacinti, Antonella Viterbo

Anticancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Castration-resistance prostate cancer: what is in the pipeline?
Cosimo DE Nunzio, Fabrizio Presicce, Silvana Giacinti, Maria Bassanelli, Andrea Tubaro

Minerva Urol Nefrol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.
Michela Roberto, Adriana Romiti, Andrea Botticelli, Federica Mazzuca, Luana Lionetto, Maria Bassanelli

Eur J Clin Pharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate.
Silvana Giacinti, Paolo Carlini, Michela Roberto, Maria Bassanelli, Lidia Strigari

Anticancer Drugs· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.
Bassanelli Maria, Viterbo Antonella, Roberto Michela, Giacinti Silvana, Staddon Anita

Ther Adv Med Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma.
Michela Roberto, Maria Bassanelli, Elsa Iannicelli, Silvana Giacinti, Chiara D'Antonio

Case Rep Oncol Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to abiraterone in castration-resistant prostate cancer: a review of the literature.
Silvana Giacinti, Maria Bassanelli, Anna Maria Aschelter, Annalisa Milano, Michela Roberto

Anticancer Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.
Chiara D'Antonio, Annalisa Milano, Riccardo Righini, Concetta Elisa Onesti, Maria Bassanelli

Anticancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis